Surgery Partners, Inc. (NASDAQ:SGRY) Holdings Raised by Clearbridge Investments LLC

Clearbridge Investments LLC increased its position in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 1.3% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,585,530 shares of the company’s stock after purchasing an additional 73,007 shares during the quarter. Clearbridge Investments LLC’s holdings in Surgery Partners were worth $132,880,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. Quarry LP increased its stake in Surgery Partners by 133.1% during the second quarter. Quarry LP now owns 3,082 shares of the company’s stock valued at $73,000 after purchasing an additional 1,760 shares during the last quarter. DekaBank Deutsche Girozentrale boosted its holdings in shares of Surgery Partners by 102.0% in the 1st quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock valued at $80,000 after buying an additional 1,375 shares during the period. EntryPoint Capital LLC grew its position in shares of Surgery Partners by 257.1% during the 1st quarter. EntryPoint Capital LLC now owns 6,399 shares of the company’s stock valued at $191,000 after buying an additional 4,607 shares during the last quarter. Capstone Investment Advisors LLC bought a new stake in shares of Surgery Partners during the 4th quarter valued at about $211,000. Finally, MeadowBrook Investment Advisors LLC raised its stake in Surgery Partners by 15.9% during the second quarter. MeadowBrook Investment Advisors LLC now owns 12,320 shares of the company’s stock worth $293,000 after acquiring an additional 1,690 shares during the period.

Surgery Partners Stock Up 0.8 %

Shares of Surgery Partners stock opened at $32.49 on Wednesday. Surgery Partners, Inc. has a 1-year low of $22.05 and a 1-year high of $36.92. The company has a market capitalization of $4.13 billion, a P/E ratio of 44.96, a PEG ratio of 2.45 and a beta of 2.76. The business’s fifty day moving average price is $30.71 and its two-hundred day moving average price is $27.66. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.83 and a quick ratio of 1.69.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.01. The business had revenue of $762.10 million during the quarter, compared to the consensus estimate of $735.94 million. Surgery Partners had a negative net margin of 1.17% and a positive return on equity of 2.96%. The company’s quarterly revenue was up 14.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.25 earnings per share. As a group, research analysts forecast that Surgery Partners, Inc. will post 0.86 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the company. Royal Bank of Canada restated an “outperform” rating and issued a $49.00 target price on shares of Surgery Partners in a research note on Wednesday, August 7th. Macquarie began coverage on Surgery Partners in a research report on Friday, June 28th. They set an “outperform” rating and a $31.00 price objective for the company. Citigroup dropped their target price on Surgery Partners from $38.00 to $36.00 and set a “buy” rating on the stock in a research report on Wednesday, August 7th. Benchmark reiterated a “buy” rating and issued a $50.00 target price on shares of Surgery Partners in a research note on Monday, August 26th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $43.00 price target on shares of Surgery Partners in a research report on Monday, August 19th. One analyst has rated the stock with a sell rating, one has given a hold rating and six have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $39.86.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.